Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study to Evaluate Switching From a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Fixed Dose Combination (FDC) to Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) FDC in Virologically-Suppressed, HIV-1 Infected Adults

ClinicalTrials.gov ID: NCT02345226

Public ClinicalTrials.gov record NCT02345226. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 6:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3b, Randomized, Double-Blind Study to Evaluate Switching From a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Fixed Dose Combination (FDC) to Emtricitabine/Rilpivirine/ Tenofovir Alafenamide (FTC/RPV/TAF) FDC in Virologically-Suppressed, HIV-1 Infected Subjects

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to evaluate the non-inferiority of switching to emtricitabine/rilpivirine/tenofovir alafenamide (FTC/RPV/TAF) fixed dose combination (FDC) as compared to continuing the non-nucleoside reverse transcriptase inhibitor (NNRTI) regimen of efavirenz /FTC/tenofovir disoproxil fumarate (EFV/FTC/TDF) FDC in virologically-suppressed HIV-1 infected participants.

Study identification

NCT ID
NCT02345226
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Gilead Sciences
Industry
Enrollment
881 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 25, 2015
Primary completion
Jun 28, 2016
Completion
Jan 1, 2019
Last update posted
Jan 1, 2020

2015 – 2019

United States locations

U.S. sites
79
U.S. states
24
U.S. cities
60
Facility City State ZIP Site status
Maricopa Integrated Health System Phoenix Arizona 85004
Spectrum Medical Group Phoenix Arizona
AHF Research Center Beverly Hills California
Pacific Oaks Medical Group Beverly Hills California
Long Beach Education and Research Consultants Long Beach California
Kaiser Permanente Los Angeles California
Southern California Men's Medical Group Los Angeles California
Tarrant County ID Associates Los Angeles California
Kaiser Permanente Sacramento California
University of California-UC Davis Sacramento California
La Playa Medical Group and Clinical Research San Diego California
Kaiser Permanente San Francisco California
Optimus Medical San Francisco California
Kaiser Permanente San Leandro California
Los Angeles BioMedical Institute at Harbor-UCLA Medical Center Torrance California
University of Colorado Aurora Colorado
Apex Research Institute Denver Colorado
Yale University School of Medicine New Haven Connecticut
World Health Clinicians' CIRCLE CARE Center Norwalk Connecticut
Capital Medical Associates, P.C. Washington D.C. District of Columbia
Medical Faculty Associates, Inc. Washington D.C. District of Columbia
Whitman Walker Clinic Washington D.C. District of Columbia
Gary Richmond, MD, PA, Inc. Fort Lauderdale Florida
Therafirst Medical Centers Fort Lauderdale Florida
Midway Immunology & Research Center, LLC Ft. Pierce Florida
AIDS Healthcare Foundation Miami Florida
University of Miami Miami Florida
AIDS Healthcare Foundation Miami Beach Florida
Orlando Immunology Center Orlando Florida
Infectious Diseases Associates of NW Florida, P.A. Pensacola Florida
Hillsborough County Health Dept. Tampa Florida
Infectious Disease Research Institute Inc. Tampa Florida
St. Joseph's Comprehensive Research Institute Tampa Florida
AIDS Research & Treatment Center of the Treasure Coast Vero Beach Florida
Triple O Research Institute, P.A. West Palm Beach Florida
Rowan Tree Medical PA Wilton Manors Florida
AIDS Research Consortium of Atlanta Atlanta Georgia
Atlanta ID Group Atlanta Georgia
Infectious Disease Specialists of Atlanta Decatur Georgia
Mercer University School of Medicine Macon Georgia
Chatham County Health Department Savannah Georgia
The CORE Foundation Chicago Illinois
Indiana University Medical Center Indianapolis Indiana
Boston University Medical Center Boston Massachusetts
Brigham and Women's Boston Massachusetts
MetroWest Medical Center Framingham Massachusetts
Baystate Infectious Diseases Clinical Research Springfield Massachusetts
The Research Institute Springfield Massachusetts
Be Well Medical Center Berkley Michigan
Henry Ford Health System Detroit Michigan
Hennepin County Medical Center Minneapolis Minnesota
Southampton Healthcare, Inc. St Louis Missouri
Saint Michael's Medical Center Newark New Jersey
South Jersey Infectious Disease Somers Point New Jersey
Southwest CARE Center Santa Fe New Mexico
Upstate Infectious Diseases Associates Albany New York
North Shore University Hospital Manhasset New York
Columbia University Medical Center/ New York Presbyterian New York New York
Jacobi Medical Center The Bronx New York
Montefiore Medical Center The Bronx New York
University of North Carolina at Chapel Hill Chapel Hill North Carolina
Infectious Disease Consultants, PA Charlotte North Carolina
The Brody School of Medicine Greenville North Carolina
Rosedale Infectious Diseases Huntersville North Carolina
The Ohio State University Columbus Ohio
University of Pennsylvania Philadelphia Pennsylvania
The Miriam Hospital Providence Rhode Island
Medical University of South Carolina Charleston South Carolina
Central Texas Clinical Research Austin Texas
North Texas Infectious Diseases Consultants Dallas Texas
Southwest Infectious Disease Clinical Research, Inc. Dallas Texas
Trinity Health and Wellness Center/AIDS Arms, Inc. Dallas Texas
AIDS Arms, Inc./Trinity Health & Wellness Center Fort Worth Texas
Gordon E. Crofoot, MD, PA Houston Texas
Research Access Network Houston Texas
DCOL Center for Clinical Research Longview Texas
Clinical Alliance for Research & Education - Infectious Diseases, LLC (CARE-ID) Annandale Virginia
Peter Shalit, MD Seattle Washington
Premier Clinical Research Spokane Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02345226, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 1, 2020 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02345226 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →